| Methotrimeprazine in the treatment of agitation in acquired brain injury patients. | |
| | |
MedLine Citation:
|
PMID: 11260766 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Medical management of the agitation associated with acquired brain injury (ABI) has been proble matic. At least 12 distinct drugs are currently recommended in the medical literature. In recent years, on the ABI in-patient rehabilitation unit, methotrimeprazine (MTZ) has come to be the preferred drug and is used routinely for effective treatment of agitation. The objective of this paper is to describe the use and safety of MTZ in the rehabilitation of ABI patients. A retrospective chart review of all patients discharged from the ABI unit over a course of 2 years was conducted. In addition to demographics such a aetiology of ABI, sex, age, length of stay, Glasgow Coma Scale, length of posttraumatic amnesia and others, a detailed analysis was made of the multidisciplinary progress notes to determine the daily agitation status and the daily use of psychotropic medication. All notes on side effects and adverse reactions were carefully documeneted. 120 first admission recent ABI patients were discharged in the 2 year study period. Of these, 69 (57%) had some level of agitation and 56 (48%) were treated with MTZ, in doses of 2-50 mg up to four times daily. Agitation was controlled in most cases. In only two cases were significant side effects noted. While MTZ has been used as a safe and effective neuroleptic in psychiatry for over 40 years, this is the first report of its use in treating agitation in ABI. |
| | |
Authors:
|
O Maryniak; R Manchanda; A Velani |
Related Documents
:
|
3361106 - Epidemiology of needlestick injury in emergency medical service personnel. 20656346 - Molecular imprinted macroporous chitosan coated mesoporous silica xerogels for hemorrha... 22811556 - Palliative sedation: not just normal medical practice. ethical reflections on the royal... 11215016 - Accidents in older people living at home: a community-based study assessing prevalence,... 12483796 - Assessment of mercury exposure and malaria in a brazilian amazon riverine community. 3361106 - Epidemiology of needlestick injury in emergency medical service personnel. |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Brain injury : [BI] Volume: 15 ISSN: 0269-9052 ISO Abbreviation: Brain Inj Publication Date: 2001 Feb |
Date Detail:
|
Created Date: 2001-02-22 Completed Date: 2001-07-12 Revised Date: 2006-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 8710358 Medline TA: Brain Inj Country: England |
Other Details:
|
Languages: eng Pagination: 167-74 Citation Subset: IM |
Affiliation:
|
Department of Physical Medicine and Rehabilitation, University of Western Ontario, London, Canada. olemar.medart@sympatico.ca |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Aged Aged, 80 and over Antipsychotic Agents / administration & dosage, therapeutic use* Brain Injuries / psychology* Female Humans Male Methotrimeprazine / administration & dosage, therapeutic use* Middle Aged Psychomotor Agitation / drug therapy*, etiology* |
| Chemical | |
Reg. No./Substance:
|
0/Antipsychotic Agents; 60-99-1/Methotrimeprazine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Misconceptions about brain injury among the general public and non-expert health professionals: an e...
Next Document: Neurobehavioural and cognitive profile of traumatic brain injury patients at risk for depression and...